Department of Radiology, University of Iowa, Iowa City, Iowa;
Department of Radiology, University of Iowa, Iowa City, Iowa.
J Nucl Med. 2023 Jul;64(7):1095-1101. doi: 10.2967/jnumed.123.265891. Epub 2023 May 25.
There has been significant recent interest in understanding both the frequency of nuclear medicine injection infiltration and the potential for negative impact, including skin injury. However, no large-scale study has yet correlated visualized injection site activity with actual activity measurement of an infiltrate. Additionally, current skin dosimetry approaches lack sufficient detail to account for critical factors that impact the dose to the radiosensitive epidermis. From 10 imaging sites, 1,000 PET/CT patient studies were retrospectively collected. At each site, consecutive patients with the injection site in the field of view were used. The radiopharmaceutical, injected activity, time of injection and imaging, injection site, and injection method were recorded. Net injection site activity was calculated from volumes of interest. Monte Carlo image-based absorbed dose calculations were performed using the actual geometry from a patient with a minor infiltration. The simulation model used an activity distribution in the skin microanatomy based on known properties of subcutaneous fat, dermis, and epidermis. Simulations using several subcutaneous fat-to-dermis concentration ratios were performed. Absorbed dose to the epidermis, dermis, and fat were calculated along with relative γ- and β-contributions, and these findings were extrapolated to a hypothetical worst-case (470 MBq) full-injection infiltration. Only 6 of 1,000 patients had activity at the injection site in excess of 370 kBq (10 μCi), with no activities greater than 1.7 MBq (45 μCi). In 460 of 1,000 patients, activity at the injection site was clearly visualized. However, quantitative assessment of activities averaged only 34 kBq (0.9 μCi), representing 0.008% of the injected activity. Calculations for the extrapolated 470-MBq infiltration resulted in a hypothetical absorbed dose to the epidermis of below 1 Gy, a factor of 2 lower than what is required for deterministic skin reactions. Analysis of the dose distribution demonstrates that the dermis acts as a β-shield for the radiation-sensitive epidermis. Dermal shielding is highly effective for low-energy F positrons but less so with the higher-energy positrons of Ga. When quantitative activity measurement criteria are used rather than visual, the frequency of PET infiltration appears substantially below frequencies previously published. Shallow doses to the epidermis from infiltration events are also likely substantially lower than previously reported because of absorption of β-particles in the dermis.
最近,人们对了解核医学注射渗透的频率以及潜在的负面影响(包括皮肤损伤)产生了浓厚的兴趣。然而,迄今为止,还没有大规模的研究将可见的注射部位活性与渗透的实际活性测量相关联。此外,当前的皮肤剂量学方法缺乏足够的细节来考虑影响对辐射敏感表皮剂量的关键因素。
从 10 个成像部位,回顾性地收集了 1000 例 PET/CT 患者的研究。在每个部位,均使用视野中存在注射部位的连续患者。记录放射性药物、注射量、注射和成像时间、注射部位和注射方法。从感兴趣的容积中计算出净注射部位的活性。使用轻度渗透患者的实际几何形状,通过基于蒙特卡罗的图像进行吸收剂量计算。模拟模型使用基于皮下脂肪、真皮和表皮已知特性的皮肤微观解剖的活性分布。对几种皮下脂肪-真皮浓度比进行了模拟。计算了表皮、真皮和脂肪的吸收剂量,以及γ和β相对贡献,并将这些发现外推到假设的最坏情况(470MBq)全注射渗透。
在 1000 名患者中,只有 6 名患者的注射部位活性超过 370kBq(10μCi),没有活性超过 1.7MBq(45μCi)。在 1000 名患者中,460 名患者的注射部位活性明显可见。然而,对活性的定量评估平均仅为 34kBq(0.9μCi),占注射活性的 0.008%。对假设的 470MBq 渗透进行的计算导致表皮的假设吸收剂量低于 1Gy,比确定性皮肤反应所需的剂量低 2 倍。剂量分布的分析表明,真皮对辐射敏感的表皮起到β屏蔽的作用。对于低能 F 正电子,真皮屏蔽非常有效,但对于 Ga 的高能正电子则不然。
当使用定量活性测量标准而不是视觉时,PET 渗透的频率明显低于以前发表的频率。由于β粒子在真皮中的吸收,渗透事件对表皮的浅层剂量也可能远低于以前报道的剂量。